CELL CLEAN-UP
Key protein boosts cellular ‘recycling’ system to protect against herpes virus
Research reveals that the TBK1 protein is key to maintaining cell viability during infection.
Key protein boosts cellular ‘recycling’ system to protect against herpes virus
Research reveals that the TBK1 protein is key to maintaining cell viability during infection.
Imperial launches its first public health online degree
The Global Master of Public Health, developed alongside Coursera, is Imperial's first fully-online degree in the health field.
Feature
How can we accelerate the elimination of viral hepatitis?
A global panel of experts have published their key recommendations to advance the fight against viral hepatitis.
Should you get a flu jab?
We asked Imperial virologist Professor Wendy Barclay for some words of wisdom on who should be getting the seasonal flu vaccine.
Killer immune cells fend off viruses with a helping hand from key proteins
New research reveals how killer cell immunoglobin-like receptors (KIRs) can strengthen the immune system’s response to HIV-1, HCV and HTLV-1 infection
Flu virus could evolve resistance to pandemic drug
The influenza virus can evolve resistance to an anti-flu drug currently in development for use in pandemics, a study has found.
Audio
Podcast: Cancer-causing virus, feeding the world and updating The Planets
In this edition: The latest research into a cancer-causing virus, a sustainable agriculture hero turns 80, and The Planets get a scientific update.
Cancer-causing virus HTLV-1 changes DNA loops, affecting thousands of genes
A human virus that causes a rare form of leukaemia increases the risk of disease by changing the way DNA loops inside our cells.
Virus’s bug-busting tactics inspire new approach to tackling infections
Fresh insights into how viruses infect bacteria could provide the basis for a new way to tackle antimicrobial resistance (AMR).
Virus’s ‘taste’ for unusual sugar could lead to new cancer treatments
The way in which a rare virus attacks cells could hold the key to new therapies for aggressive brain and lung cancers, according to new research.